Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has qualified for and completed either study 06-009 (NCT00423813) or 06-008 (NCT00371137).~* Subject is able, in the opinion of the investigator, to take Xyrem® for approximately 9-1/2 months.~Exclusion Criteria:~* Subject terminated early from either study 06-009 or 06-008.~* Subject experienced any serious adverse event related to study drug in either study 06-009 or 06-008.~* Subject, in the opinion of the investigator, experienced an adverse event in 06-009 or 06-008 that may prevent him/her from safely participating in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).